HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


Mineralocorticoid Treatment for Sudden Sensorineural Hearing Loss

Signup
Browse Studies

City:   Portland
State:   Oregon
Zip Code:   97239
Conditions:   Hearing Loss, Sensorineural
Purpose:   The standard of care treatment of sudden hearing loss uses a type of steroid called glucocorticoid. Examples of glucocorticoids are prednisone, methylprednisolone and dexamethasone. Not everybody recovers hearing with glucocorticoid treatment. Fludrocortisone is a different type of steroid called mineralocorticoid. Unlike glucocorticoids, which work by reducing inflammation, mineralocorticoids work by changing salt and fluid balance. In animal studies, fludrocortisone is at least as effective as glucocorticoid in preserving hearing. Fludrocortisone is not approved for the treatment of sudden hearing loss. The purpose of this study is to test whether fludrocortisone can treat sudden hearing loss.
Study Summary:  
Criteria:   Inclusion Criteria: - Age 18 or older - Idiopathic sudden sensorineural hearing loss within 3 months - Failure to recover hearing with glucocorticoid treatment or inability to tolerate glucocorticoid Exclusion Criteria: - Other diagnosis for the sudden hearing loss - Concurrent systemic use of another steroid - Hypersensitivity to fludrocortisone - Systemic fungal infection - Hypertension requiring two or more medications - Pitting edema - Cardiomegaly - Congestive heart failure - Electrolyte abnormality - Concurrent use of barbiturates, phenytoin, fosphenytoin, rifampin, or rifapentine
NCT ID:   NCT01186185
Primary Contact:   Principal Investigator
Anh Nguyen-Huynh, MD PhD
Oregon Health and Science University

Anh Nguyen-Huynh, MD PhD
Phone: 503-494-8135
Email: nguyanh@ohsu.edu
Backup Contact:   Email: shib@ohsu.edu
Yong-Bing Shi, MD PhD
Phone: 503-494-7954
Location Contact:   Portland, Oregon 97239
United States

Anh Nguyen-Huynh
Phone: 503-260-9192
Email: nguyanh@ohsu.edu

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   May 22, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"
First Name:  
Last Name:  
Email Address:  
Confirm Email:    
Daytime Phone (eg. 555-555-5555):  
City:  
State:
Zip Code:    
Best Time to Call:  
Questions/Comments:  
  • NEARBY STUDIES

Within 25 Miles

Pediatric Depression - Portland OR

Depression - Portland OR

Treatment Resistant Depression - Portland OR

Sexual Dysfunction (Due to Anti-Depressants) - Portland OR

Multiple Sclerosis - Portland OR

Asthma (Ages 18-65) - Portland OR

Anti-Depressant Induced Sexual Dysfunction - Portland OR

Memory Loss - Portland OR

COPD (Emphysema and Chronic Bronchitis) - Portland OR

Within 50 Miles

Within 100 Miles

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Eugene OR

Low Back Pain and Constipation - Eugene OR

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.